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 Gestational diabetes mellitus (GDM), i.e., glucose intol-
erance diagnosed for the fi rst time during pregnancy, is 
associated with unfavorable pregnancy outcomes for both 
the mother and the fetus ( 1 ). These GDM-related risks, 
including fetal macrosomia, are mediated, at least partly, 
via disturbed glucose and/or lipid metabolism. The asso-
ciation of high maternal glucose levels with fetal macro-
somia is well-documented ( 1 ), but macrosomia is also 
observed in diabetic pregnancies with satisfactory glycemic 
control ( 2 ). It has been suggested that maternal plasma 
lipids might be stronger determinants for fetal growth 
than plasma glucose levels ( 3 ) [reviewed in ( 4 )]. In some 
studies, concentrations of maternal serum triglycerides 
have associated positively ( 5 ) and HDL cholesterol nega-
tively with neonatal birth weight ( 6 ). 
 Hyperlipidemia of pregnancy is a well-characterized 
phenomenon and considered necessary to satisfy the 
needs of the developing fetus ( 7 ) [reviewed in ( 4 )]. How-
ever, excessive hyperlipidemia may not solely be a benign 
condition. High levels of maternal plasma cholesterol 
have been associated with increased expression of pro-
teins involved in cholesterol metabolism in the placenta 
( 8 ), which could potentially modulate fetal development. 
Hypercholesterolemia of the mother may also trigger patho-
genic events in the fetal aorta and determine susceptibility 
to atherosclerosis later in life ( 9 ). Similarly, the offspring 
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 Exclusion criteria for all subjects included diabetes, undiag-
nosed thyroid disease (abnormal serum thyroid-stimulating hor-
mone concentration), anemia, use of insulin, age <18 years, oral 
corticosteroid treatment, alcohol or drug abuse, multiple preg-
nancy, physical disability, signifi cant cooperation diffi culties 
(e.g., insuffi cient language skills), or history of severe psychiatric 
disorder or hypertension. 
 An oral glucose tolerance test (OGTT) (75 g) was performed 
on all subjects at weeks 22–29 of pregnancy, with the exception of 
three subjects with OGTT performed at weeks 31–33, and was 
considered diagnostic for GDM if any of the measures were path-
ological. The following diagnostic thresholds were used: fasting 
plasma glucose >5.3 mmol/l, 1 h plasma glucose   10.0 mmol/l, 
or 2 h plasma glucose   8.6 mmol/l ( 21 ). The GDM group (n = 
22) consisted of women having a pathological OGTT, while the 
control subjects (n = 30) had a normal OGTT during pregnancy 
and no history of previous GDM. 
 Weight and height were measured at the time of enrollment 
and at each maternity clinic visit. The prepregnancy weight was 
self-reported. The newborns were weighed directly after the 
delivery on a digital baby scale. The relative weight was calcu-
lated using Finnish standards adjusted for sex and gestational 
age ( 22 ). 
 As all study subjects were obese, they received dietary and ex-
ercise information leafl ets ( 20, 23, 24 ). In addition, subjects who 
were diagnosed for GDM received dietary counseling and infor-
mation of diabetes in the primary health care center. In case 
plasma glucose concentrations in home measurements repeat-
edly exceeded 5.5 mmol/l before breakfast or 7.8 mmol/l 1 h 
after a meal, insulin treatment was initiated. If insulin was started 
before the third trimester, samples were taken and subjects were 
excluded from further analysis (n = 1) due to potential interfer-
ence of insulin therapy on lipid metabolism. One subject was 
treated with metformin (starting at week 15). 
 The study was performed according to the principles of the 
Declaration of Helsinki and was approved by the Ethical Commit-
tee of the Helsinki University Central Hospital. 
 Methods 
 Serum samples were collected from all subjects during preg-
nancy (at I, II, and III trimester corresponding to pregnancy 
weeks 10–14, 22–25, and 34–36) and at 6 weeks, 6 months, and 12 
months postpartum. All samples were stored at   80°C until ana-
lyzed. Fasting plasma glucose, alanine transaminase (ALAT), se-
rum insulin, and thyroid-stimulating hormone concentrations 
were determined by routine hospital laboratory methods. Serum 
cholesterol and cholesterol precursors (squalene, lanosterol, 
  8-cholestenol, desmosterol, and lathosterol), cholestanol, and 
plant sterols (campesterol, sitosterol, and avenasterol) were as-
sayed by gas-liquid chromatography (GLC), as described ( 25 ). 
Shortly, serum squalene and noncholesterol sterols were quanti-
fi ed from nonsaponifi able serum-based materials by capillary 
GLC (Agilent 6890N Network GC system; Agilent Technologies, 
Wilmington, DE) equipped with a 50 m long nonpolar Ultra 2 
capillary column (5% phenyl-methyl siloxane; Agilent Technolo-
gies) with 5  -cholestane as internal standard ( 25 ). The serum 
values of squalene and noncholesterol sterols are expressed as 
concentrations (  g/dl) or ratios to cholesterol (100 ×   mol/mmol 
of cholesterol) by dividing squalene and noncholesterol sterol 
concentrations with the cholesterol value of the same GLC run in 
order to eliminate the effect of different cholesterol levels ( 26 ). 
We also calculated the lathosterol/sitosterol ratio, which refl ects 
cholesterol synthesis ( 26 ). 
 Serum phospholipids, triglycerides, total cholesterol, HDL 
cholesterol, and LDL cholesterol concentrations were determined 
by enzymatic methods, phospholipids with DiaSys Diagnostic 
of GDM mothers have an increased risk for obesity and 
T2D later in life ( 10, 11 ). 
 The lipid changes associated with T2D, i.e., low HDL 
cholesterol, elevated serum triglycerides, and small dense 
LDL, are well-described ( 12 ). Furthermore, we have shown 
that T2D ( 13 ) as well as obesity ( 14 ) associate with in-
creased cholesterol synthesis and decreased intestinal cho-
lesterol absorption effi ciency. As GDM is proposed to 
mimic T2D in many ways (insulin resistance, increase in 
body fat), similar lipid changes would also be expected to 
occur in GDM. However, studies investigating serum lipids 
and lipoproteins in GDM have been controversial, show-
ing an increase, a decrease, or no change in serum triglyc-
eride, total cholesterol, or LDL cholesterol levels ( 8, 15, 
16 ) [reviewed in ( 4 )]. 
 In addition to cholesterol, serum contains cholesterol 
precursors [squalene, lanosterol (14  -trimethyl-5  -cholest-
8,24-dien-3  -ol),   8-cholestenol (5  -cholest-8-en-3  -ol), 
desmosterol (cholest-5,24-dien-3  -ol), and lathosterol 
(5  -cholest-7-en-3  -ol)], which in many conditions, such 
as T2D, refl ect cholesterol synthesis, cholestanol (a de-
rivative of cholesterol), and plant sterols (campesterol, 
sitosterol, and avenasterol), which refl ect cholesterol ab-
sorption effi ciency ( 17 ). Serum noncholesterol sterols in 
pregnancy have been examined previously in only two 
studies. The fi rst compared normal and cholestatic preg-
nancy just before delivery and 6 weeks postpartum ( 18 ), 
and the latter the effect of consuming plant stanol ester 
margarine on sterols in normal pregnancy in the fi rst and 
third trimester and 1 month postpartum ( 19 ). To our 
knowledge, no studies exist that explore squalene and 
noncholesterol sterols in subjects with GDM, nor is there 
data available about potential associations of maternal 
noncholesterol sterols with neonatal birth weight. 
 Thus, the present study was undertaken to examine se-
rum cholesterol precursors, cholestanol, and plant sterols 
in obese subjects with GDM or normal glucose tolerance 
during pregnancy and the following 12 months postpar-
tum. Furthermore, as maternal lipids might be determi-
nants of fetal growth, we investigated whether these 
maternal sterols associate with neonatal birth weight. We 
assumed that serum squalene and noncholesterol sterols 
could be the most sensitive markers refl ecting potential 
changes in cholesterol metabolism during GDM even 
when glycemic control is satisfactory. 
 MATERIALS AND METHODS 
 Subjects 
 All study subjects were participants of the Finnish RADIEL 
study, described previously in detail ( 20 ), and consisted of all eli-
gible subjects from the RADIEL study’s control arm. Pregnant 
women (n = 52) classifi ed as at risk for developing GDM (BMI 
>30 kg/m 2 ) were enrolled in the present study at the time of 
their fi rst visit to the maternity clinics in Southern Finland. With 
the exception of two subjects (Estonian and Russian origin) all 
study subjects were of Finnish origin. All participants signed an 
informed consent form. 
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System (Holzheim, Germany), and the others with Thermo 
Konelab GO (Thermo Scientifi c, Vantaa, Finland). 
 Statistics 
 Statistical analyses were performed with IBM SPSS 19.0 statis-
tics program. Normality was tested before further analyses. 
Blom’s formula was used to normalize skewed distributions ( 27 ). 
Student’s  t -test was used to analyze differences in BMI and weight 
between groups, and paired  t -test for serum lipid and sterol 
changes within groups during pregnancy and postpartum. Gen-
eral linear model (GLM) for repeated measures was used for test-
ing differences between the groups in the function of time using 
age and prepregnancy BMI as covariates. When signifi cant differ-
ences ( P < 0.05) were detected, GLM univariate variance analysis 
was applied to examine differences between the groups at each 
time-point using age and the corresponding BMI as covariates. 
Spearman’s correlation was used to analyze correlation between 
parameters. Multiple stepwise regression analysis was performed 
separately at each trimester to determine if maternal parameters 
associated with neonatal birth weight. Independent variables in 
the analyses included maternal prepregnancy BMI; weight gain 
(kg); age; trimester-specifi c plasma glucose and serum insulin 
concentrations; serum total cholesterol, HDL cholesterol, and 
LDL cholesterol; serum triglycerides; phospholipids; and squa-
lene and noncholesterol sterols (concentration and ratio to 
cholesterol, analyzed separately). Multicollinearity between the 
covariates was not detected during analyses.  P < 0.05 was used as 
an inclusion criterion in the model.  P < 0.05 was considered sta-
tistically signifi cant. 
 RESULTS 
 Characteristics of the study subjects at the time of en-
rollment in their fi rst trimester are shown in  Table 1 . The 
GDM and control groups did not differ in age, nor were 
there any differences in plasma ALAT; serum total, HDL, 
and LDL cholesterol; or serum total triglyceride or phos-
pholipid levels. Plasma glucose was higher in the GDM 
group than in the control group ( P < 0.001), but insulin 
levels or insulin/glucose ratios did not differ between the 
groups. All study subjects were obese (BMI >30 kg/m 2 ), as 
called for in the inclusion criteria. Subjects with GDM had 
higher BMI than the controls, i.e., 36.9 versus 33.3 kg/m 2 
( P < 0.01), and this difference remained signifi cant 
throughout pregnancy. Therefore, in all further GLM 
analyses BMI was used as a covariate. Subjects with GDM 
gained less weight during pregnancy than the control sub-
jects, i.e., 3.6 ± 0.7 (SE) kg versus 7.6 ± 0.9 kg, respectively 
( P < 0.01). 
 The groups did not differ in terms of smoking (three 
control subjects smoked before pregnancy, two of them 
stopped when pregnant), history of preeclampsia (in 
three control subjects), use of pregnancy vitamins (Multi-
tabs Raskaus, Pfi zer Oy) or vitamin D supplements (73% 
vs. 85%, GDM vs. control, NS), development of hyperten-
sion (three subjects in both groups), preeclampsia (two 
subjects in controls), or hepatogestosis (none) during 
pregnancy. None of the subjects had a previous or newly 
diagnosed lipid disorder, or used statins. 
 Neonatal birth weights (3,753 ± 118 g vs. 3,566 ± 82 g), 
gestational age (39.7 ± 0.27 weeks vs. 40.3 ± 0.24 weeks), 
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or relative birth weights did not differ signifi cantly be-
tween the newborns of GDM or control mothers. None 
of the newborns were small or large for age (i.e., weight 
<2 SD or >2 SD). 
 Plasma glucose, serum insulin, and lipids in pregnancy 
and postpartum 
 During pregnancy, plasma fasting glucose concentra-
tion was signifi cantly higher in the GDM group than in the 
control group (GLM repeated measures,  P < 0.001) and 
remained higher during the follow-up period 12 months 
postpartum (GLM repeated measures,  P < 0.05) ( Table 1 ). 
All plasma glucose values were indicative of good glycemic 
control. Serum insulin levels did not differ between the 
groups at any measured time-point, and neither did the 
insulin/glucose ratio refl ecting insulin sensitivity. 
 Serum total cholesterol increased equally in both groups 
by 30% and serum triglycerides almost doubled during 
pregnancy ( Table 1 ). The concentration of HDL choles-
terol reached its peak in the second trimester in both 
groups, while that of LDL cholesterol reached its peak in 
the third trimester. Serum phospholipids increased by 
20% in both control and GDM pregnancies ( P < 0.05). All 
measured lipids, i.e., serum total, LDL, HDL cholesterol, 
triglycerides, and phospholipids, were higher during preg-
nancy than 12 months postpartum, and did not differ sig-
nifi cantly between the groups. 
 In the control group, but not in the GDM group, the 
change in BMI during pregnancy (from prepregnancy to 
third trimester) correlated with the change in serum in-
sulin concentration ( r = 0.624,  P = 0.006), and with the 
change in plasma glucose concentration ( r = 0.433,  P < 
0.05). The serum insulin and insulin/glucose ratio in the 
third trimester correlated with weight change in both 
groups ( r = 0.681,  P < 0.01 in controls, and  r = 0.498,  P < 
0.05 in GDM). There was no signifi cant correlation be-
tween pregnancy weight change (prepregnancy to third 
trimester) and change in serum total, HDL, or LDL cho-
lesterol, or serum triglyceride or phospholipid levels, but 
the weight change from the fi rst to the third trimester cor-
related to the change in serum phospholipids in controls 
( r = 0.422,  P < 0.05). 
 Squalene and noncholesterol sterols in pregnancy 
 In the fi rst trimester, serum concentrations of squalene 
and noncholesterol sterols, as well as their ratios to choles-
terol, were similar in both groups, with the exception of 
slightly higher serum   8-cholestenol concentration and 
ratio to cholesterol ( P < 0.05) in the subjects who were 
later diagnosed for GDM than in the control subjects 
( Table 2 ,  Fig. 1 ). Also, their ratio of serum lathosterol to 
that of sitosterol, refl ecting cholesterol synthesis, was 
higher ( P < 0.05). 
 During pregnancy, the serum concentrations of lanosterol, 
desmosterol, cholestanol, campesterol, sitosterol, and avenas-
terol increased from the fi rst to the third trimester in both 
groups ( Table 2 ). On the contrary to the controls, serum con-
centrations of   8-cholestenol and lathosterol did not in-
crease signifi cantly in the GDM group. Serum lathosterol 
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 Fig.  1. The ratios of serum squalene and noncholesterol sterols to cholesterol (100 ×   mol/mmol of cho-
lesterol) in I, II, and III trimester of pregnancy, and 6 weeks, 6 months, and 12 months postpartum (p.p.) in 
control subjects (open circles) and subjects with GDM (fi lled circles). Values are mean ± SE. * P < 0.05, con-
trols versus GDM. GLM adjusted for BMI. 
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 Fig.  2. Correlation between neonatal birth weight (g) and maternal serum squalene concentration (  g/dl) in the second trimester of 
control pregnancies (n = 30) (A) and pregnancies affected by GDM (n = 22) (B). 
concentration differed during pregnancy between GDM and 
control groups ( P < 0.05, GLM repeated measures). The con-
centration of serum squalene, however, increased ( P < 0.01) 
only in the GDM group, and differed from the controls dur-
ing pregnancy (GLM repeated measures,  P < 0.05). In the 
second trimester, serum squalene concentration was higher 
in the GDM group than in controls ( P < 0.05). 
 As the cholesterol levels also increased substantially, 
only the ratios of desmosterol and cholestanol to choles-
terol increased signifi cantly ( P < 0.0001 in both groups), 
while that of   8-cholestenol decreased in both groups ( P < 
0.01 in GDM;  P < 0.05 in controls) ( Fig. 1 ). This decrease 
was somewhat greater in subjects with GDM than in the 
controls ( P < 0.05), but the ratio of   8-cholestenol to cho-
lesterol was higher in the GDM group already in the fi rst 
trimester [22.3 ± 1.8 vs. 18.2 ± 1.1 (100 ×   mol/mmol of 
cholesterol), GDM vs. controls,  P < 0.05]. The ratio of la-
thosterol to cholesterol decreased during pregnancy only 
in the GDM group ( P < 0.05). Although the ratios of sitos-
terol ( Fig. 1 ), as well as those of campesterol and avenas-
terol to cholesterol (data not shown), tended to be lower 
in the GDM group than in the control group, the differ-
ences were not statistically signifi cant. However, during 
pregnancy, the ratio of squalene to cholesterol differed 
between the GDM and control group ( P < 0.05, GLM re-
peated measures). In GDM pregnancies, the serum ratio 
of squalene to cholesterol (100 ×   mol/mmol of choles-
terol) was signifi cantly higher in the second (11.5 ± 0.5 vs. 
9.1 ± 0.5,  P < 0.01) and third (12.1 ± 0.8 vs. 10.0 ± 0.7,  P < 
0.05) trimester than in the controls. 
 Pregnancy-related change in BMI or weight did not cor-
relate signifi cantly to the change in squalene or noncho-
lesterol sterols during pregnancy in either of the groups. 
 Squalene and noncholesterol sterols postpartum 
 Six weeks after delivery, in both groups, the concentra-
tion of serum cholestanol reduced to half of that of the 
third trimester, and serum cholesterol and lathosterol 
concentrations decreased by 20–30% ( Table 2 ). The most 
marked increase at 6 weeks postpartum was seen in 
the ratio of desmosterol to cholesterol by 25–30% ( P < 
0.01) in both groups ( Fig. 2 ). The ratios of squalene and 
  8-cholestenol to cholesterol also increased similarly, in 
both groups, 6 weeks after the delivery ( P < 0.05). At 12 
months postpartum, the ratio of   8-cholestenol was 
slightly higher in GDM subjects than in the controls ( P < 
0.05). Plant sterol ratios to cholesterol did not markedly 
change after delivery. 
 At 6 weeks postpartum, 84% of mothers were breast-
feeding, at 6 months 48%, and at 12 months 21%, similarly 
in both groups. 
 Correlations 
 In the fi rst trimester, the ratios of desmosterol and la-
thosterol to cholesterol correlated negatively to the ratios 
of campesterol, sitosterol, and cholestanol to cholesterol 
in both groups, suggesting that cholesterol absorption and 
synthesis were in homeostasis at this point. However, this 
homeostasis was partly lost in the third trimester of the 
pregnancy in the GDM group ( Table 3 ). At that time, in 
the control group, the ratios of both desmosterol and la-
thosterol to cholesterol correlated negatively to the ratio 
of cholestanol to cholesterol, and the ratio of desmosterol 
to cholesterol correlated negatively to ratios of campes-
terol and sitosterol to cholesterol, but in the GDM group, 
only the ratio of desmosterol to cholesterol correlated to 
the ratio of cholestanol to cholesterol. 
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 In the fi rst and second trimester, plasma glucose con-
centration did not signifi cantly correlate with serum squa-
lene or noncholesterol sterols, with the exception of a 
negative correlation to serum cholestanol concentration 
in the controls in the fi rst trimester. Serum insulin corre-
lated negatively with the ratio of cholestanol to cholesterol 
( r =   0.495,  P < 0.05) in the fi rst trimester and positively 
with the ratio of desmosterol to cholesterol in the fi rst ( r = 
0.542,  P < 0.05) and second trimester ( r = 0.618,  P < 0.01) 
in the control group only. 
 In the third trimester, plasma glucose and serum insulin 
concentrations correlated with the serum ratio of squa-
lene to cholesterol in control subjects ( r = 0.445,  P < 0.05 
and  r = 0.572,  P < 0.01, respectively). Also, the change in 
serum insulin levels during pregnancy correlated with the 
change in squalene (both serum concentration and ratio 
to cholesterol,  r = 0.560 and  r = 0.500,  P < 0.05, respec-
tively) in the control subjects, but not in the GDM group. 
 Plasma ALAT levels did not correlate with serum squa-
lene or noncholesterol sterol concentrations or ratios to 
cholesterol. 
 Neonatal birth weight and maternal lipids 
 We fi rst looked at potential correlations between third 
trimester maternal serum lipids and birth weight of the 
newborns. There were no correlations between maternal 
serum triglyceride or total, LDL, or HDL cholesterol con-
centrations and birth weight, but in the control group, se-
rum phospholipids correlated with birth weight and with 
relative birth weight ( r = 0.462 and  r = 0.450,  P < 0.05, re-
spectively). Analysis of serum squalene and noncholes-
terol sterols revealed a correlation between birth weight 
and both maternal serum cholestanol concentration ( r = 
0.437,  P < 0.05) and the ratio of cholestanol to cholesterol 
( r = 0.452,  P < 0.05) in the controls. On the other hand, in 
the GDM subjects, maternal serum desmosterol concen-
trations correlated with birth weight ( r = 0.528,  P = 0.01). 
However, no signifi cant correlations were found between 
maternal plasma glucose or insulin levels with birth weight 
in either of the groups. 
 We next investigated the possibility that the change in 
maternal lipids or noncholesterol sterols during preg-
nancy (i.e., between the fi rst and third trimester), rather 
than a single measurement in the third trimester, would 
associate with birth weight. No correlations were observed 
between changes in serum total, LDL, or HDL cholesterol 
levels, or serum triglycerides or phospholipids and birth 
weight. Examination of correlations of the change in se-
rum squalene and noncholesterol sterols during preg-
nancy with birth weight revealed that only the change 
in the ratio of cholestanol to cholesterol correlated with 
birth weight both in the controls ( r = 0.519,  P < 0.01) and 
in the GDM group ( r = 0.454,  P < 0.05). 
 Because the main difference between GDM and control 
pregnancies was the fi nding of higher squalene levels al-
ready in the second trimester, we next examined whether 
serum squalene correlated with birth weight at that point. 
There was a strong correlation between second trimester 
maternal serum squalene concentration ( r = 0.760,  P < 
0.001) ( Fig. 2 ) and the ratio of squalene to cholesterol 
with neonatal birth weight ( r = 0.614,  P = 0.002) and with 
relative birth weight ( r = 0.658,  P = 0.001) in GDM sub-
jects. Analysis of other sterols during the second trimester 
revealed that serum lathosterol and desmosterol ( r = 
0.504,  P < 0.05,  r = 0.582,  P < 0.01, respectively) and   8-
cholestenol ( r = 0.505,  P < 0.05) concentrations also 
showed signifi cant, although less profound, correlations 
with birth weight and also with relative birth weight. Thus, 
it appeared that second trimester maternal cholesterol 
synthesis markers correlated with fetal weight in subjects 
with GDM. No correlation was detected in control 
subjects. 
 To further analyze the relative strength of maternal pa-
rameters associating with neonatal birth weight, we per-
formed stepwise multiple regression analysis separately at 
each trimester. When maternal prepregnancy BMI, weight 
 TABLE 3. Spearman correlation coeffi cients of the serum ratios of squalene and noncholesterol sterols to 
cholesterol (100 ×   mol/mmol of cholesterol) in the controls and subjects with GDM in the third 
trimester of pregnancy 
Squalene Lanosterol   8-Cholestenol Lathosterol Desmosterol Sitosterol Campesterol
Control (n = 27)
 Lanosterol 0.562 b — — — — — —
   8-Cholestenol 0.297 0.317 — — — — —
 Lathosterol 0.078 0.076 0.753 c — — — —
 Desmosterol 0.190 0.011 0.488 a 0.446 a — — —
 Sitosterol 0.216 0.267   0.133   0.140   0.358 — —
 Campesterol 0.162 0.203   0.206   0.230   0.429 a 0.950 c —
 Cholestanol 0.121 0.226   0.242   0.407 a   0.536 b 0.563 b 0.592 b 
GDM (n = 21)
 Lanosterol 0.621 b — — — — — —
   8-Cholestenol 0.454 a 0.622 b — — — — —
 Lathosterol 0.370 0.370 0.788 c — — — —
 Desmosterol 0.009   0.056   0.090 0.094 — — —
 Sitosterol 0.433 0.338 0.169 0.134   0.290 — —
 Campesterol 0.484 a 0.217 0.149 0.221   0.345 0.899 c —
 Cholestanol 0.146 0.088 0.074   0.074   0.500 a 0.561 b 0.474 a 
 a P < 0.05.
 b P < 0.01.
 c P < 0.001.
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gain, age, and trimester-specifi c plasma glucose and serum 
insulin levels, serum total, LDL, and HDL cholesterol, se-
rum triglycerides and squalene and noncholesterol sterols 
were included as independent variables in the analysis, no 
signifi cant associations were detected in the fi rst trimester. 
In the second trimester, only maternal serum squalene 
(concentration and ratio to cholesterol) (R 2 of the model: 
0.425,  P < 0.01) and in the third trimester only serum des-
mosterol concentration (R 2 of the model: 0.295 and  P < 
0.05) associated with neonatal birth weight in the GDM 
group. In the control group using the same independent 
variables, only the third trimester serum cholestanol (con-
centration and ratio to cholesterol) associated with birth 
weight (R 2 of the model: 0.191,  P < 0.05). 
 DISCUSSION 
 The present study explores, for the fi rst time, serum 
squalene and noncholesterol sterols in pregnancies af-
fected by obesity and GDM, and further follows these vari-
ables 12 months postpartum. We proposed that impaired 
glucose metabolism during pregnancy could be associated 
with changes in cholesterol metabolism, detectable by ana-
lyzing serum squalene and noncholesterol sterols. As ma-
ternal lipids, along with glucose levels, have been shown 
to be important determinants of fetal growth, we also ex-
plored the potential associations between maternal squa-
lene and noncholesterol sterols and neonatal birth weight. 
The main new fi ndings in our study were that, in obesity, 
GDM associated with higher cholesterol synthesis markers 
in the fi rst trimester, and elevated serum squalene levels in 
the second and third trimester of pregnancy, and that ma-
ternal serum squalene and cholesterol synthesis markers 
correlated with birth weight. 
 Effect of obesity, serum insulin, and plasma glucose 
 Because we enrolled only pregnant women who were at 
increased risk for developing GDM, all our study subjects 
were obese. Previously, we have shown that obesity and 
weight change infl uence cholesterol metabolism ( 14, 28, 
29 ). Therefore, it was somewhat surprising that the change 
in weight did not associate with the change of any of the 
measured sterols, though it did associate with serum insu-
lin and plasma glucose concentrations. It may be that 
pregnancy itself is metabolically such a demanding state 
requiring increased cholesterol synthesis ( 18 ), that minor 
potential changes induced by weight change in greatly 
obese subjects could be unmasked. 
 Although GDM mimics T2D, it also differs greatly re-
garding diagnostic criteria, i.e., diagnosis is based on 2 h 
OGTT and the diagnostic thresholds are much lower. This 
is based on fi ndings in the HAPO study showing continu-
ous association of glucose levels to pregnancy complica-
tions, even with glucose levels below the diagnostic values 
for GDM ( 1 ). By current defi nition, all the subjects in our 
present study group had GDM, based on OGTT, and their 
plasma glucose values were higher than in the control sub-
jects, but they were in good glycemic control and had normal 
nonpregnant plasma glucose values . Although we have 
previously shown that insulin regulates cholesterol metab-
olism to a greater extent than obesity ( 30 ), and that cho-
lesterol metabolism was altered already in subjects with 
impaired fasting glucose in the METSIM study ( 31 ), the 
plasma glucose values in our previous studies have been 
higher. The tight glycemic control in GDM subjects might 
have attenuated the impact of glycemic variation on cho-
lesterol metabolism. 
 Lipids and lipoproteins in pregnancy 
 Pregnancy hyperlipidemia, as previously described, con-
sisted of the increase of serum total cholesterol and triglyc-
erides. Furthermore, all measured lipids, i.e., LDL and 
HDL cholesterol and serum phopholipids were higher in 
pregnancy than postpartum. The controversy observed in 
previous studies exploring lipid levels in GDM is not com-
pletely clear, but might be due to varying diagnostic crite-
ria used for GDM over the years, use of insulin, and 
differences in glycemic control and steroid hormone lev-
els during pregnancy ( 32 ). We did not observe any signifi -
cant differences in serum total, LDL, or HDL cholesterol, 
triglycerides, or phospholipids in our GDM subjects with 
good glycemic control, as compared with the controls. It 
thus seems that noncholesterol sterols are more sensitive 
markers than serum and lipoprotein lipids to show subtle 
changes occurring in cholesterol metabolism in GDM. 
 Cholesterol homeostasis 
 In many conditions, but not always ( 33 ), cholesterol syn-
thesis and absorption are in homeostasis, i.e., increased 
cholesterol synthesis associates with decreased cholesterol 
absorption [reviewed in ( 17 )]. This is refl ected by nega-
tive correlation between synthesis markers and absorption 
markers. In the present study, cholesterol synthesis and 
absorption were in homeostasis in the beginning of preg-
nancy, but in the third trimester in pregnancies affected 
by GDM, only desmosterol and cholestanol were interre-
lated, suggesting that homeostasis was partially lost in the 
GDM group. 
 Squalene 
 The observations that the serum   8-cholestenol con-
centration and ratio to cholesterol, as well as the serum 
lathosterol/sitosterol ratio, were higher in the fi rst trimes-
ter in the GDM group than in the controls, suggest that 
cholesterol synthesis was somewhat elevated in pregnan-
cies affected by GDM, which is in accordance with our pre-
vious studies regarding T2D ( 13, 29 ). In the second or 
third trimester of pregnancy, the groups did not differ in 
serum concentrations or ratios of noncholesterol sterols, 
cholestanol, or plant sterols. However, the fi nding that the 
ratio of squalene to cholesterol in the second and third 
trimester was higher in subjects with GDM than in the con-
trols is of interest. 
 Squalene is a nonsteroidal precursor of cholesterol, 
and it is both absorbed from the intestine and synthesized 
in the adipose tissue, liver, and skin. Adipose tissue syn-
thesizes and stores high amounts of squalene, but releases 
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interest that maternal cholestasis during pregnancy has 
been shown to program metabolic disease and obesity in 
the offspring ( 38, 39 ). 
 The observation that the ratio of   8-cholestenol de-
creased during pregnancy is in accordance with the previ-
ous study ( 18 ). It might be that during pregnancy the 
activity of the enzyme converting   8-cholestenol to lathos-
terol is enhanced more than the other enzymes in the 
Kandutsch-Russell cholesterol synthesis chain. The fi nd-
ing that in GDM subjects both the ratios of   8-cholestenol 
and lathosterol decreased during pregnancy, while that of 
desmosterol increased, suggests that the cholesterol syn-
thesis pathway through the desmosterol, i.e., the Bloch 
route, might have been preferred instead of the Kan-
dutsch-Russell route. There are many situations in which 
either of the pathways are preferred [reviewed in ( 40 )], 
but the importance of that is not yet known. The marked 
rise in the serum ratio of desmosterol in both groups after 
delivery, again apparently refl ects increased cholesterol 
synthesis through the Bloch pathway, required in lactation 
for secretion of cholesterol to human milk, which is very 
rich in desmosterol ( 41 ). Taken together, it may be that, 
in pregnancy, cholesterol synthesis via the Bloch pathway 
is preferred, especially if the pregnancy is affected by 
GDM. 
 Neonatal weight and maternal cholesterol 
 Previous studies have shown variable associations be-
tween maternal serum lipids/lipoproteins and neonatal 
weight. Many, but not all ( 42 ), studies are limited to only 
one varying time-point measurement during pregnancy. 
Neonatal birth weight has been shown to correlate with 
maternal serum triglycerides in pregnancies with normal 
glucose tolerance ( 43–45 ) or GDM ( 3, 46 ), and negatively 
with serum HDL cholesterol concentration ( 6 ), but only 
in cases with obesity ( 42 ). In our study, only third trimes-
ter maternal serum phospholipids correlated with birth 
weight in controls, but not in pregnancies affected by 
GDM. In diabetic pregnancy, altered lipoproteins in the 
maternal side could potentially affect the quantity and 
quality of lipids available for the fetal needs. Phospho-
lipid transfer protein is expressed in placental endothe-
lium and enhances cholesterol effl ux by interaction with 
ABCA1 ( 47 ). HDL cholesterol concentration peaked al-
ready in second trimester, as reported previously and also 
in other studies, and HDL cholesterol and phospholipids 
might be important for fetal development in the early 
pregnancy. 
 Cholesterol and fetal cholesterol synthesis are crucial 
for embryonic development. This is demonstrated by 
rare genetic disorders caused by defects in cholesterol 
biosynthesis, for example, Smith-Lemli-Opitz syndrome, 
in which inactivating mutations in the gene coding for 
7-dehydrocholesterol reductase results in accumulation 
of 7-dehydrocholesterol, lack of cholesterol, and severe 
congenital abnormalities ( 48, 49 ). However, even in new-
borns with 7-dehydrocholesterol reductase-null mutations, 
there is a detectable amount of cholesterol in serum, sug-
gesting the presence of an exogenous cholesterol source. 
it extremely slowly, if at all ( 34 ). Squalene can be obtained 
from the diet, but it is unlikely that dietary causes would 
account for the higher serum squalene levels in the GDM 
group, because subjects with GDM did not receive any 
dietary counseling favoring consumption of squalene-
rich foods (e.g., olive oil). Squalene, in contrast to the 
noncholesterol sterols, is mainly carried in triglyceride-
rich lipoproteins ( 35 ), but serum triglyceride levels did 
not explain the observed difference, as serum triglycer-
ides did not differ between the groups. Serum squalene 
concentration has been shown to associate with visceral 
fat, but not with BMI, in subjects with normal glucose tol-
erance ( 36 ). In the present study, BMI did not correlate 
with serum squalene level, nor is it likely to explain the 
differences between the groups, as the results were ad-
justed for BMI. However, in the controls, serum insulin 
correlated with serum squalene concentration in the 
third trimester. Whether this correlation was lost in GDM 
subjects, or whether the lack of correlation simply refl ects 
insensitivity of single serum insulin measures, requires 
further investigation and larger study material. 
 What do the elevated serum squalene levels then indi-
cate in GDM pregnancy? In many conditions, serum squa-
lene refl ects cholesterol synthesis, but less frequently than 
serum   8-cholestenol, or desmosterol and lathosterol [re-
viewed in ( 17 )]. Serum squalene has been high in obesity, 
metabolic syndrome, and T2D, i.e., in situations with in-
creased cholesterol synthesis from redundancy in the sub-
strate pool. In the second trimester of pregnancy, serum 
squalene concentration correlated positively to serum la-
nosterol,   8-cholestenol, and desmosterol concentrations, 
and most likely simply refl ects increased cholesterol syn-
thesis. These results suggest that serum squalene might be 
the most sensitive marker to detect changes in cholesterol 
metabolism induced by mild disturbances in glucose me-
tabolism in obese GDM subjects. 
 Noncholesterol sterols 
 During pregnancy, only the ratios of desmosterol and 
cholestanol to cholesterol increased signifi cantly in both 
groups. It has previously been shown that serum cholesta-
nol increases more in cholestatic pregnancies than in non-
cholestatic ones, but even in noncholestatic pregnancies, 
the rise in serum cholestanol is substantial, while the 
amounts of serum plant sterols do not change ( 18 ), a situ-
ation resembling our present fi ndings in both groups. The 
increase of serum cholestanol may indicate either in-
creased cholestanol synthesis from cholesterol or de-
creased elimination via biliary excretion, i.e., mild 
cholestasis, frequently present in pregnancy, or both ( 18 ). 
The role of maternal serum cholestanol and its association 
to birth weight in control pregnancies is ambiguous, espe-
cially if cholestanol refl ects mild cholestasis. In the cord 
blood of fetuses, serum cholestanol has been shown to be 
high, and to drastically reduce during the fi rst year of life 
( 37 ). Further studies are required to examine whether as-
sociations exist between maternal and cord-blood choles-
tanol, and whether increased serum cholestanol simply 
refl ects cholestasis in pregnancy. In this respect, it is of 
 at Terkko - N
ational Library of Health Sciences, on M
ay 16, 2016
w
w
w
.jlr.org
D
ow
nloaded from
 
GDM, squalene, and noncholesterol sterols 2653
 REFERENCES 
  1 .  Metzger ,  B. E. ,  L. P.  Lowe ,  A. R.  Dyer ,  E. R.  Trimble ,  U.  Chaovarindr , 
 D. R.  Coustan ,  D. R.  Hadden ,  D. R.  McCance ,  M.  Hod ,  H. D. 
 McIntyre ,  et al .  2008 .  Hyperglycemia and adverse pregnancy out-
comes.  N. Engl. J. Med.  358 :  1991 – 2002 . 
  2 .  Evers ,  I. M. ,  H. W.  de Valk ,  B. W.  Mol ,  E. W.  ter Braak , and  G. 
H.  Visser .  2002 .  Macrosomia despite good glycaemic control in 
Type I diabetic pregnancy; results of a nationwide study in The 
Netherlands.  Diabetologia .  45 :  1484 – 1489 . 
  3 .  Schaefer-Graf ,  U. M. ,  K.  Graf ,  I.  Kulbacka ,  S. L.  Kjos ,  J. 
 Dudenhausen ,  K.  Vetter , and  E.  Herrera .  2008 .  Maternal lipids as 
strong determinants of fetal environment and growth in pregnan-
cies with gestational diabetes mellitus.  Diabetes Care .  31 :  1858 – 1863 . 
  4 .  Herrera ,  E. , and  H.  Ortega-Senovilla .  2010 .  Disturbances in lipid 
metabolism in diabetic pregnancy - Are these the cause of the prob-
lem?  Best Pract. Res. Clin. Endocrinol. Metab.  24 :  515 – 525 . 
  5 .  Knopp ,  R. H. ,  M. S.  Magee ,  C. E.  Walden ,  B.  Bonet , and  T. J. 
 Benedetti .  1992 .  Prediction of infant birth weight by GDM screen-
ing tests. Importance of plasma triglyceride.  Diabetes Care .  15 : 
 1605 – 1613 . 
  6 .  Clausen ,  T. ,  T. K.  Burski ,  N.  Oyen ,  K.  Godang ,  J.  Bollerslev , and 
 T.  Henriksen .  2005 .  Maternal anthropometric and metabolic fac-
tors in the fi rst half of pregnancy and risk of neonatal macrosomia 
in term pregnancies. A prospective study.  Eur. J. Endocrinol.  153 : 
 887 – 894 . 
  7 .  Potter ,  J. M. , and  P. J.  Nestel .  1979 .  The hyperlipidemia of preg-
nancy in normal and complicated pregnancies.  Am. J. Obstet. 
Gynecol.  133 :  165 – 170 . 
  8 .  Marseille-Tremblay ,  C. ,  M.  Ethier-Chiasson ,  J. C.  Forest ,  Y.  Giguere , 
 A.  Masse ,  C.  Mounier , and  J.  Lafond .  2008 .  Impact of maternal cir-
culating cholesterol and gestational diabetes mellitus on lipid me-
tabolism in human term placenta.  Mol. Reprod. Dev.  75 :  1054 – 1062 . 
  9 .  Napoli ,  C. ,  C. K.  Glass ,  J. L.  Witztum ,  R.  Deutsch ,  F. P.  D'Armiento , 
and  W.  Palinski .  1999 .  Infl uence of maternal hypercholesterol-
aemia during pregnancy on progression of early atherosclerotic 
lesions in childhood: Fate of Early Lesions in Children (FELIC) 
study.  Lancet .  354 :  1234 – 1241 . 
 10 .  Pettitt ,  D. J. ,  K. A.  Aleck ,  H. R.  Baird ,  M. J.  Carraher ,  P. H.  Bennett , 
and  W. C.  Knowler .  1988 .  Congenital susceptibility to NIDDM. 
Role of intrauterine environment.  Diabetes .  37 :  622 – 628 . 
 11 .  Krishnaveni ,  G. V. ,  S. R.  Veena ,  J. C.  Hill ,  S.  Kehoe ,  S. C.  Karat , and 
 C. H.  Fall .  2010 .  Intrauterine exposure to maternal diabetes is as-
sociated with higher adiposity and insulin resistance and clustering 
of cardiovascular risk markers in Indian children.  Diabetes Care .  33 : 
 402 – 404 . 
 12 .  American Diabetes Association .  1998 .  Management of dyslipidemia 
in adults with diabetes.  Diabetes Care .  21 :  179 – 182 . 
 13 .  Gylling ,  H. , and  T. A.  Miettinen .  1997 .  Cholesterol absorption, syn-
thesis, and LDL metabolism in NIDDM.  Diabetes Care .  20 :  90 – 95 . 
 14 .  Miettinen ,  T. A. , and  H.  Gylling .  2000 .  Cholesterol absorption 
effi ciency and sterol metabolism in obesity.  Atherosclerosis .  153 : 
 241 – 248 . 
 15 .  Koukkou ,  E. ,  G. F.  Watts , and  C.  Lowy .  1996 .  Serum lipid, lipopro-
tein and apolipoprotein changes in gestational diabetes mellitus: a 
cross-sectional and prospective study.  J. Clin. Pathol.  49 :  634 – 637 . 
 16 .  Hollingsworth ,  D. R. , and  S. M.  Grundy .  1982 .  Pregnancy-associated 
hypertriglyceridemia in normal and diabetic women. Differences 
in insulin-dependent, non-insulin-dependent, and gestational dia-
betes.  Diabetes .  31 :  1092 – 1097 . 
 17 .  Miettinen ,  T. A. ,  H.  Gylling , and  M. J.  Nissinen .  2011 .  The role 
of serum non-cholesterol sterols as surrogate markers of absolute 
cholesterol synthesis and absorption.  Nutr. Metab. Cardiovasc. Dis. 
 21 :  765 – 769 . 
 18 .  Nikkilä ,  K. ,  S.  Riikonen ,  M.  Lindfors , and  T. A.  Miettinen .  1996 . 
 Serum squalene and noncholesterol sterols before and after deliv-
ery in normal and cholestatic pregnancy.  J. Lipid Res.  37 :  2687 – 2695 . 
 19 .  Laitinen ,  K. ,  E.  Isolauri ,  L.  Kaipiainen ,  H.  Gylling , and  T. A. 
 Miettinen .  2009 .  Plant stanol ester spreads as components of a bal-
anced diet for pregnant and breast-feeding women: evaluation of 
clinical safety.  Br. J. Nutr.  101 :  1797 – 1804 . 
 20 .  Rönö ,  K. ,  B.  Stach-Lempinen ,  M. M.  Klemetti ,  R. J.  Kaaja , 
 M.  Pöyhönen-Alho ,  J. G.  Eriksson , and  S. B.  Koivusalo .  2014 . 
 Prevention of gestational diabetes through lifestyle intervention: 
study design and methods of a Finnish randomized controlled mul-
ticenter trial (RADIEL).  BMC Pregnancy Childbirth .  14 :  70 . 
Furthermore, in cord blood of healthy fetuses, plant 
sterol concentrations were 40–50% of the maternal 
levels, indicating active maternal-fetal sterol transport 
( 37 ). 
 There is growing evidence that the fetus depends on the 
mother’s cholesterol metabolism mostly in the beginning 
of pregnancy, before fetal endogeneous cholesterol syn-
thesis begins [reviewed in ( 50 )]. Interestingly, already at 
that time, cholesterol synthesis appears to be slightly up-
regulated in subjects who were later diagnosed for GDM. 
Recent data analyzing cholesterol sterols in amniotic fl u-
ids at different stages of pregnancy showed that the ratios 
of lanosterol and lathosterol to cholesterol increases after 
19 weeks of gestation, refl ecting the beginning of fetal 
cholesterol synthesis ( 51, 52 ). Thus, the most sensitive pe-
riod regarding fetal cholesterol requirements for the 
mother, is the time up to 19 weeks of pregnancy. It is of 
note, that apparently at that time maternal serum squa-
lene levels were higher in GDM pregnancies and corre-
lated signifi cantly to neonatal birth weight. Also, in 
multiple stepwise regression analysis, only second trimes-
ter serum squalene associated with birth weight of the in-
fants born to GDM mothers. It is conceivable that serum 
squalene refl ects increased maternal cholesterol synthesis 
and increased fuel supply for the growing fetus. This as-
sumption is supported also by the association of another 
cholesterol synthesis marker, i.e., maternal serum desmo-
sterol in the third trimester, with birth weight. Taken to-
gether, these fi ndings suggest that in this fairly small group 
of obese GDM subjects, activity of maternal cholesterol 
metabolism might have contributed to neonatal weight. At 
least partly due to their good glycemic control, GDM sub-
jects did not have any large-for-date newborns. Thus, fur-
ther studies and larger study populations are required to 
investigate whether maternal cholesterol synthesis could 
play any clinical role in fetal macrosomia, often complicat-
ing GDM pregnancies with poor glycemic control. Also, it 
remains to be seen if the differences observed in GDM 
pregnancies in the present study apply also in normal 
weight pregnancies. 
 CONCLUSION 
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